2009-06-05 13:06:08 -

PharMerica Corporation (NYSE: PMC) announced the results of the Company’s 2009 annual meeting of stockholders held on Thursday, June 4, 2009.

At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the annual meeting of stockholders in 2010: Gregory S. Weishar, Thomas P. Mac Mahon, Frank E. Collins, Esq., W. Robert

Dahl, Jr., Marjorie W. Dorr, Dr. Thomas P.

Gerrity, Daniel N. Mendelson, and Dr. Robert A. Oakley. Stockholders also voted to approve the Company’s Amended and Restated 2007 Omnibus Incentive Plan and ratified the appointment of PricewaterhouseCoopers as the Company’s independent registered public accounting firm for the year ending December 31, 2009.



About PharMerica

PharMerica Corporation is a leading institutional pharmacy services company servicing healthcare facilities in the United States. PharMerica operates institutional pharmacies in 40 states. PharMerica’s customers are institutional healthcare providers, such as nursing centers, assisted living facilities, hospitals and other long-term care providers. The Company also provides pharmacy management services to long-term care hospitals.

From time to time, PharMerica Corporation makes “forward-looking statements,” as defined within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are based on management's current expectations and involve known and unknown risks, uncertainties, contingencies and other factors that could cause results, performance or achievements to differ materially from those anticipated. Forward-looking statements include, among other things, statements relating to the Company’s current and expected financial results, overall economic, financial and political conditions, industry trends, as well as other especially relevant risks as detailed in the Company’s filings with the Securities and Exchange Commission. The information set forth herein should be read in light of such risks. The Company assumes no obligation to update the information contained in this press release.


PharMerica CorporationMichael J. Culotta, 502-627-7475Executive
Vice President and Chief Financial Officer